Hypercalcemia affects up to 30% of patients with cancer. 1 It has been seen in most cancers but is most common in patients with non-small cell lung cancer, breast cancer, multiple myeloma, head and ...

New research attempts to answer some of the mystery related to the causes and impact of hypercalcemia in patients with newly diagnosed multiple myeloma. Hypercalcemia is caused by many factors in ...

Hypercalcemia of malignancy (HCM) is the most common metabolic complication seen in patients with cancer, and is associated with a high degree of morbidity and mortality. It affects an estimated 2%–30 ...

September 19, 2007--Cinacalcet ( Sensipar, Amgen) may emerge as an important new therapeutic option for patients with inoperable parathyroid carcinoma, researchers report. According to the results of ...

Q: I had routine blood work done at my annual checkup. The calcium level was just above the top of the normal range. The rest ...

Hypercalcemia is a condition in which there are abnormal levels of calcium in the blood. The normal calcium levels in blood serum range from 8.8 mg/dL to 10.8 mg/dL. 90% of hypercalcemia cases are ...

Hypercalcemia is most common in those who have later-stage malignancies and predicts a poor prognosis for those with it. The most common causes include humoral hypercalcemia of malignancy mediated by ...

Hypercalcemia is a common and potentially life‐threatening complication of malignancy, arising in up to 40 percent of patients with advanced neoplasms. It results from tumour‐driven disruptions in ...

Background A 54-year-old man presented to the emergency department of his local hospital with a 1-year history of fatigue, weight loss, and constipation. He had abused alcohol for many years, and his ...